Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT04949581 |
Other study ID # |
p.t.REC/012/003250 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 15, 2021 |
Est. completion date |
September 30, 2021 |
Study information
Verified date |
June 2021 |
Source |
Cairo University |
Contact |
al shaymaa sh abd el azeim, lecturer |
Phone |
01033771553 |
Email |
alshaymaa.shaaban[@]pt.cu.edu.eg |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The aim of this study is to investigate the effect of bioelectric therapy on sternal
instability in patients with median sternotomy after heart valve surgery.
Description:
Valvular heart disease constitutes a growing healthcare problem with a general prevalence of
2%-5% and a prevalence of 13% after the age of 75 years Heart valve surgery can be a
lifesaving procedure for patients with severe symptomatic heart valve disease. Nevertheless,
following the surgery, up to 27% of patients may require readmission within 30 days after
discharge. Following heart valve surgery, some patients report anxiety and worries related to
readmission and reoperations, postoperative complications, and deconditioning which may
prevent or delay return to work and limit activities of daily living.Over the past 30 years,
bone-growth stimulators have become a critical component in fracture care. They can be
classified into four categories: direct-current (DC) devices, inductive coupling, noninvasive
capacitive coupling, and low-intensity ultrasound. Microcurrent electrical stimulation ( MES)
is the therapeutic use of constant (DC) and pulsed (interrupted) currents, where the stimulus
amplitude is in the micro amperage (millionth of an ampere) range. MES is defined as those of
less than 1 mA or 1000 μ, (MES < 1 mA). This form of electrical stimulation tends to be
applied at the suspensory or very low sensory level and they are not designed to stimulate
muscle contraction. Generators that produce MES were originally called microcurrent
electrical neuromuscular stimulators (MENS). However, the stimulation pathway is not the
usual neural pathway, and they are not designed to stimulate muscle contraction.
Consequently, this type of generator was subsequently referred to as a microcurrent
electrical stimulator (MES). The use of MES may be an adjunctive modality in the treatment of
fractures or injury sites, especially fractures prone to nonunion. Fracture healing may be
accelerated by passing a monophasic current through the fracture site. Getting the current
into the bony area without an invasive technique is difficult.forty subjects will be
allocated to two groups; one group will receive micro-current therapy and routine cardiac
rehabilitation program both for four weeks and the control group will receive the cardiac
rehabilitation program only for four weeks.